INTERNATIONAL BIOTECHNOLOGY TRUST PLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 307 filers reported holding REPLIGEN CORP in Q4 2019. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2019$1,841,000
-10.7%
24,0000.0%0.85%
+11.4%
Q2 2019$2,061,00024,0000.76%
Other shareholders
REPLIGEN CORP shareholders Q4 2019
NameSharesValueWeighting ↓
Conestoga Capital Advisors, LLC 1,291,805$53,532,0002.79%
Ranger Investment Management 919,366$38,099,0002.72%
Monashee Investment Management LLC 100,000$4,144,0001.75%
Lisanti Capital Growth, LLC 49,450$2,049,0001.36%
Pier Capital, LLC 175,565$7,275,0001.26%
SANDLER CAPITAL MANAGEMENT 221,070$9,161,0000.99%
PALISADE CAPITAL MANAGEMENT, LP 630,333$26,121,0000.98%
AWM Investment Company, Inc. 120,000$4,973,0000.88%
Stephens Investment Management Group LLC 857,714$35,544,0000.86%
Summit Creek Advisors LLC 79,066$3,276,0000.68%
View complete list of REPLIGEN CORP shareholders